Pfizer (PFE)
(Delayed Data from NYSE)
$28.90 USD
+0.12 (0.42%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $28.92 +0.02 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Pfizer Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2,158.00 | 31,407.00 | 22,025.00 | 9,652.00 | 16,302.00 |
Depreciation/Amortization & Depletion | 6,290.00 | 5,064.00 | 5,191.00 | 4,777.00 | 6,010.00 |
Net Change from Assets/Liabilities | -2,172.00 | -4,456.00 | 12,804.00 | -275.00 | -4,031.00 |
Net Cash from Discontinued Operations | 15.00 | -6.00 | 91.00 | 1,186.00 | 0.00 |
Other Operating Activities | 2,411.00 | -2,742.00 | -7,531.00 | -937.00 | -5,693.00 |
Net Cash From Operating Activities | 8,700.00 | 29,267.00 | 32,580.00 | 14,403.00 | 12,588.00 |
Property & Equipment | -3,907.00 | -3,236.00 | -2,711.00 | -2,252.00 | -2,176.00 |
Acquisition/ Disposition of Subsidiaries | -43,430.00 | -22,997.00 | 0.00 | 0.00 | -10,861.00 |
Investments | 15,239.00 | 6,682.00 | -19,517.00 | -1,672.00 | 9,304.00 |
Other Investing Activities | -179.00 | 3,768.00 | -317.00 | -347.00 | -213.00 |
Net Cash from Investing Activities | -32,278.00 | -15,783.00 | -22,546.00 | -4,271.00 | -3,945.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | -2,000.00 | 0.00 | 425.00 | -8,471.00 |
Issuance (Repayment) of Debt | 28,262.00 | -3,298.00 | -1,007.00 | 1,219.00 | -1,864.00 |
Increase (Decrease) Short-Term Debt | 7,683.00 | -218.00 | -96.00 | -13,974.00 | 10,628.00 |
Payment of Dividends & Other Distributions | -9,247.00 | -8,983.00 | -8,729.00 | -8,440.00 | -8,043.00 |
Other Financing Activities | -631.00 | -335.00 | 16.00 | 11,122.00 | -736.00 |
Net Cash from Financing Activities | 26,066.00 | -14,834.00 | -9,816.00 | -9,649.00 | -8,485.00 |
Effect of Exchange Rate Changes | -40.00 | -165.00 | -59.00 | -8.00 | -32.00 |
Net Change In Cash & Equivalents | 2,448.00 | -1,515.00 | 159.00 | 475.00 | 125.00 |
Cash at Beginning of Period | 468.00 | 1,983.00 | 1,825.00 | 1,350.00 | 1,225.00 |
Cash at End of Period | 2,917.00 | 468.00 | 1,983.00 | 1,825.00 | 1,350.00 |
Diluted Net EPS | 0.37 | 5.47 | 3.85 | 1.71 | 2.87 |
Fiscal Year End for Pfizer Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,171.00 | 3,123.00 | 2,158.00 | 5,518.00 | 7,894.00 |
Depreciation/Amortization & Depletion | 3,467.00 | 1,736.00 | 6,290.00 | 4,620.00 | 3,060.00 |
Net Change from Assets/Liabilities | -6,871.00 | -3,336.00 | -2,172.00 | -10,622.00 | -9,423.00 |
Net Cash from Discontinued Operations | -12.00 | -5.00 | 15.00 | -11.00 | -1.00 |
Other Operating Activities | -445.00 | -437.00 | 2,411.00 | 3,955.00 | -1,530.00 |
Net Cash From Operating Activities | -691.00 | 1,090.00 | 8,700.00 | 3,460.00 | 4.00 |
Property & Equipment | -1,341.00 | -704.00 | -3,907.00 | -2,863.00 | -2,053.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -43,430.00 | -25.00 | -25.00 |
Investments | 7,691.00 | 2,435.00 | 15,239.00 | -18,199.00 | -19,549.00 |
Other Investing Activities | -18.00 | 0.00 | -179.00 | -193.00 | -543.00 |
Net Cash from Investing Activities | 6,332.00 | 1,732.00 | -32,278.00 | -21,282.00 | -22,170.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -2,250.00 | -1,250.00 | 28,262.00 | 28,262.00 | 29,562.00 |
Increase (Decrease) Short-Term Debt | 61.00 | -923.00 | 7,683.00 | -92.00 | 36.00 |
Payment of Dividends & Other Distributions | -4,752.00 | -2,372.00 | -9,247.00 | -6,932.00 | -4,618.00 |
Other Financing Activities | -449.00 | -386.00 | -631.00 | -613.00 | -576.00 |
Net Cash from Financing Activities | -7,390.00 | -4,931.00 | 26,066.00 | 20,624.00 | 24,403.00 |
Effect of Exchange Rate Changes | -46.00 | -28.00 | -40.00 | -39.00 | -7.00 |
Net Change In Cash & Equivalents | -1,794.00 | -2,137.00 | 2,448.00 | 2,764.00 | 2,229.00 |
Cash at Beginning of Period | 2,917.00 | 2,917.00 | 468.00 | 468.00 | 468.00 |
Cash at End of Period | 1,123.00 | 780.00 | 2,917.00 | 3,233.00 | 2,698.00 |
Diluted Net EPS | 0.01 | 0.55 | -0.59 | -0.42 | 0.41 |